John Fung to Liver Transplantation
This is a "connection" page, showing publications John Fung has written about Liver Transplantation.
Connection Strength
23.802
-
The Sky Is Not Falling. Liver Transpl. 2022 03; 28(3):353-354.
Score: 0.467
-
Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary Pancreat Dis Int. 2017 Feb; 16(1):27-32.
Score: 0.333
-
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
Score: 0.333
-
Liver transplantation for nonalcoholic steatohepatitis in young patients. Transpl Int. 2016 Apr; 29(4):418-24.
Score: 0.314
-
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2012 May; 10(5):540-6.
Score: 0.234
-
Future prospects in immunosuppression for liver transplantation. Liver Transpl. 2011 Nov; 17 Suppl 3:S54-9.
Score: 0.231
-
Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl. 2011 Nov; 17 Suppl 3:S1-9.
Score: 0.231
-
Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford). 2011 Sep; 13(9):651-5.
Score: 0.227
-
Liver transplantation for fatty liver disease. J Dig Dis. 2011 Feb; 12(1):36-7.
Score: 0.220
-
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010 Dec; 10(12):2665-72.
Score: 0.217
-
Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant. 2010 Sep-Oct; 24(5):701-8.
Score: 0.213
-
Themes of liver transplantation. Hepatology. 2010 Jun; 51(6):1869-84.
Score: 0.210
-
Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery. 2010 Sep; 148(3):582-8.
Score: 0.207
-
Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome. Liver Transpl. 2009 Nov; 15(11):1448-57.
Score: 0.201
-
Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl. 2009 Sep; 15(9):1003-6.
Score: 0.199
-
Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl. 2009 Jan; 15(1):49-53.
Score: 0.190
-
Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008 Oct; 14(10):1406-11.
Score: 0.187
-
Predicting immunosuppressant dosing in the early postoperative period with noninvasive indocyanine green elimination following orthotopic liver transplantation. Liver Transpl. 2008 Jan; 14(1):46-52.
Score: 0.177
-
Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl. 2007 Dec; 13(12):1633-6.
Score: 0.176
-
Dental health status of liver transplant candidates. Liver Transpl. 2007 Feb; 13(2):280-6.
Score: 0.166
-
Liver transplantation in China. Liver Transpl. 2007 Feb; 13(2):182.
Score: 0.166
-
Preservation solutions in liver transplantation: what are the options? Liver Transpl. 2006 Feb; 12(2):196-8.
Score: 0.155
-
Is adult-to-adult living donor liver transplantation a viable option for liver replacement? Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):70-1.
Score: 0.155
-
Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation. 2005 Dec 27; 80(12):1692-8.
Score: 0.154
-
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005 Nov; 11(11):1425-30.
Score: 0.153
-
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation. 2005 Sep 27; 80(6):859-64.
Score: 0.152
-
Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice). Liver Transpl. 2005 Aug; 11(8):861-71.
Score: 0.150
-
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005 Jun; 11(6):679-83.
Score: 0.148
-
Immunosuppression in liver transplantation: beyond calcineurin inhibitors. Liver Transpl. 2005 Mar; 11(3):267-80.
Score: 0.146
-
The pitfall of the cystic duct biliary anastomosis in right lobe living donor liver transplantation. Liver Transpl. 2004 Dec; 10(12):1549-50.
Score: 0.143
-
Liver transplantation in patients with HIV infection. Liver Transpl. 2004 Oct; 10(10 Suppl 2):S39-53.
Score: 0.142
-
[Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
Score: 0.141
-
De novo breast cancer in patients with liver transplantation: University of Pittsburgh's experience and review of the literature. Liver Transpl. 2004 Jan; 10(1):1-6.
Score: 0.134
-
Liver transplantation for growing teratoma syndrome: report of a case. Liver Transpl. 2003 Nov; 9(11):1222-4.
Score: 0.133
-
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference. Transplantation. 2023 10 01; 107(10):2238-2246.
Score: 0.132
-
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation. 2003 Sep 15; 76(5):827-32.
Score: 0.132
-
Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl. 2003 Sep; 9(9):954-60.
Score: 0.131
-
Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
Score: 0.131
-
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. Exp Clin Transplant. 2003 Jun; 1(1):48-55.
Score: 0.129
-
Rapamycin: friend, foe, or misunderstood? Liver Transpl. 2003 May; 9(5):469-72.
Score: 0.128
-
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003 Mar; 9(3):239-47.
Score: 0.127
-
Living donor liver transplantation: ethics and safety. Transplant Proc. 2003 Feb; 35(1):51-2.
Score: 0.126
-
Advances in hepatitis B virus infection. Transplant Proc. 2003 Feb; 35(1):342-4.
Score: 0.126
-
Alcoholic liver disease and transplantation. Transplant Proc. 2003 Feb; 35(1):358-60.
Score: 0.126
-
Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002 Nov 15; 74(9):1290-6.
Score: 0.124
-
Intrahepatic biliary anatomy of living adult liver donors: correlation of mangafodipir trisodium-enhanced MR cholangiography and intraoperative cholangiography. AJR Am J Roentgenol. 2002 Nov; 179(5):1281-6.
Score: 0.124
-
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transpl. 2002 Nov; 8(11):1007-13.
Score: 0.124
-
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
Score: 0.123
-
Experiences relating to management of biliary tract complications following liver transplantation in 96 cases. Chin Med J (Engl). 2002 Oct; 115(10):1533-7.
Score: 0.123
-
The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl. 2002 Sep; 8(9):775-7.
Score: 0.123
-
Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report. Liver Transpl. 2002 Sep; 8(9):838-40.
Score: 0.123
-
The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 2002 Sep; 8(9):841-5.
Score: 0.123
-
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. Transplant Proc. 2002 Aug; 34(5):1540-1.
Score: 0.122
-
Transjugular intrahepatic portosystemic shunt for liver transplantation. Hepatobiliary Pancreat Dis Int. 2002 May; 1(2):179-82.
Score: 0.120
-
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl. 2002 Jan; 8(1):40-6.
Score: 0.117
-
Fungal infection in liver transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:18-23.
Score: 0.117
-
De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl. 2001 Nov; 7(11 Suppl 1):S109-18.
Score: 0.116
-
Modified temporary end-to-side portocaval shunt in liver and small bowel transplantation. Pediatr Transplant. 2001 Oct; 5(5):381-2.
Score: 0.115
-
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation. 2001 Sep 27; 72(6):1091-7.
Score: 0.115
-
Induction Therapy With Antithymocyte Globulin and Delayed Calcineurin Inhibitor Initiation for Renal Protection in Liver Transplantation: A Multicenter Randomized Controlled Phase II-B Trial. Transplantation. 2022 05 01; 106(5):997-1003.
Score: 0.114
-
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl. 2001 Jul; 7(7):623-30.
Score: 0.113
-
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Transplantation. 2001 Apr 27; 71(8):1102-6.
Score: 0.112
-
Ischemic preconditioning: application in clinical liver transplantation. Liver Transpl. 2001 Apr; 7(4):300-1.
Score: 0.111
-
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
Score: 0.110
-
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. Transplant Proc. 2001 Feb-Mar; 33(1-2):1342-4.
Score: 0.110
-
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):1352.
Score: 0.110
-
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc. 2001 Feb-Mar; 33(1-2):1482-3.
Score: 0.110
-
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc. 2001 Feb-Mar; 33(1-2):1486-7.
Score: 0.110
-
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation. 2001 Jan 27; 71(2):267-71.
Score: 0.110
-
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg. 2000 Oct; 232(4):490-500.
Score: 0.107
-
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant. 2021 03; 21(3):1039-1055.
Score: 0.106
-
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl. 2000 Jul; 6(4):434-9.
Score: 0.105
-
Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg. 2000 Feb; 35(2):283-9; discussion 289-90.
Score: 0.102
-
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation. 1999 Oct 15; 68(7):1058-61.
Score: 0.100
-
Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transpl Surg. 1999 Sep; 5(5):421-8.
Score: 0.099
-
Toward tolerance: lessons learned from liver transplantation. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S90-7.
Score: 0.098
-
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
Score: 0.098
-
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg. 1999 Mar; 5(2):144-50.
Score: 0.096
-
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood. 1999 Feb 01; 93(3):1113-4.
Score: 0.096
-
Immunosuppressive therapy. Surg Clin North Am. 1999 Feb; 79(1):59-76.
Score: 0.096
-
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc. 1999 Feb-Mar; 31(1-2):700-1.
Score: 0.096
-
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation. 1998 Nov 27; 66(10):1395-8.
Score: 0.094
-
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg. 1998 Nov; 4(6):448-54.
Score: 0.094
-
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression. Ann Transplant. 2018 Oct 26; 23:751-757.
Score: 0.094
-
Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci. 1998 Sep; 43(9):1931-7.
Score: 0.093
-
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
Score: 0.091
-
Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
Score: 0.091
-
Reconstruction of an abnormal hepatic vein in a donor liver: a case report. Transplantation. 1998 May 15; 65(9):1265-6.
Score: 0.091
-
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018 05; 102(5):727-743.
Score: 0.091
-
Kaposi's sarcoma in liver transplant recipients on FK506. Transplantation. 1998 Apr 27; 65(8):1140.
Score: 0.091
-
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 02; 24(2):233-245.
Score: 0.089
-
Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation. 1997 Dec 15; 64(11):1582-4.
Score: 0.088
-
Tolerance and chimerism in liver transplantation. Transplant Proc. 1997 Nov; 29(7):2817-8.
Score: 0.088
-
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. Surgery. 2017 09; 162(3):525-536.
Score: 0.085
-
Hemophilia Liver Transplantation Observational Study. Liver Transpl. 2017 06; 23(6):762-768.
Score: 0.085
-
Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
Score: 0.085
-
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis. Lancet Gastroenterol Hepatol. 2017 08; 2(8):595-603.
Score: 0.085
-
Liver transplantation for unresectable colorectal liver metastases: A systematic review. J Surg Oncol. 2017 Sep; 116(3):288-297.
Score: 0.085
-
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg. 1997 Mar; 3(2):118-29.
Score: 0.084
-
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation. 1997 Feb 15; 63(3):471-2.
Score: 0.083
-
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1168-9.
Score: 0.083
-
Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med. 1997 Jan-Feb; 6(1):40-4.
Score: 0.083
-
Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation. 1996 Dec 15; 62(11):1584-7.
Score: 0.082
-
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS One. 2016; 11(11):e0166998.
Score: 0.082
-
Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016 11; 22(11):1469-1481.
Score: 0.082
-
"Pants" vein jump graft for portal vein and superior mesenteric vein thrombosis in transplantation of the liver. J Am Coll Surg. 1996 Nov; 183(5):527-8.
Score: 0.082
-
Split liver transplantation in adults. World J Gastroenterol. 2016 Sep 07; 22(33):7500-6.
Score: 0.081
-
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg. 1996 Aug; 183(2):117-25.
Score: 0.080
-
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection. Am J Transplant. 2016 10; 16(10):2816-2835.
Score: 0.080
-
Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation. Inflamm Bowel Dis. 2016 07; 22(7):1670-8.
Score: 0.080
-
Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
Score: 0.079
-
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 1996 May; 88(1):124-9.
Score: 0.079
-
Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant. 2016 09; 16(9):2532-44.
Score: 0.079
-
Performance of multi-layer feedforward neural networks to predict liver transplantation outcome. Methods Inf Med. 1996 Mar; 35(1):12-8.
Score: 0.078
-
Cadaveric liver donors; what are the limits? Transplant Proc. 1996 Feb; 28(1):21-3.
Score: 0.078
-
The rationale for equitable liver allocation. Clin Transpl. 1996; 325-32.
Score: 0.077
-
Adenosine Increases Hepatic Artery Flow in Liver Transplant Recipients: A Pilot Study. Transplant Proc. 2016 Jan-Feb; 48(1):116-9.
Score: 0.077
-
Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic. Liver Transpl. 2015 Dec; 21(12):1494-503.
Score: 0.077
-
Between Scylla and Charybdis. Ann Surg. 1995 Aug; 222(2):107-8.
Score: 0.075
-
Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol. 1995 Jul-Aug; 6(4):523-9.
Score: 0.075
-
Liver transplantation for hepatitis B: what have we learned and what does the future hold? Liver Transpl Surg. 1995 Jul; 1(4):274-80.
Score: 0.075
-
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
Score: 0.075
-
Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Clin Transplant. 1995 Jun; 9(3 Pt 2):262-8.
Score: 0.074
-
Transjugular intrahepatic portosystemic shunt in liver transplant recipients: indications, feasibility, and outcomes. Hepatol Int. 2015 Jul; 9(3):391-8.
Score: 0.074
-
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc. 1995 Feb; 27(1):509-10.
Score: 0.072
-
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc. 1995 Feb; 27(1):511-2.
Score: 0.072
-
Bone marrow augmentation in solid organ transplantation--any conclusions? Hepatology. 1995 Jan; 21(1):260-1.
Score: 0.072
-
Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl. 2015 Jan; 21(1):101-11.
Score: 0.072
-
Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States. Am J Transplant. 2014 Sep; 14(9):2072-80.
Score: 0.070
-
Sanguineous normothermic machine perfusion improves hemodynamics and biliary epithelial regeneration in donation after cardiac death porcine livers. Liver Transpl. 2014 Aug; 20(8):987-99.
Score: 0.070
-
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. Transplant Proc. 1994 Jun; 26(3):1211.
Score: 0.069
-
The effect of splenectomy on cardiac and liver xenografts in the nude rat. Transplant Proc. 1994 Jun; 26(3):1210.
Score: 0.069
-
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014 Jun; 29(6):1250-7.
Score: 0.069
-
Predicting outcomes after liver transplantation. A connectionist approach. Ann Surg. 1994 Apr; 219(4):408-15.
Score: 0.068
-
Oxygen consumption predicts outcome in porcine partial liver grafts. J Surg Res. 2014 Jun 15; 189(2):335-9.
Score: 0.068
-
Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant. 1994 Feb; 8(1):49-53.
Score: 0.068
-
The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. Transplantation. 2014 Jan 27; 97(2):e14-5.
Score: 0.068
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.067
-
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
Score: 0.067
-
Transfusion of older red blood cells is associated with decreased graft survival after orthotopic liver transplantation. Liver Transpl. 2013 Nov; 19(11):1181-8.
Score: 0.066
-
Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway. Transplantation. 2013 Jul 15; 96(1):17-24.
Score: 0.065
-
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc. 1993 Feb; 25(1 Pt 1):362-3.
Score: 0.063
-
Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant Proc. 1993 Feb; 25(1 Pt 1):444-5.
Score: 0.063
-
Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary Pancreat Dis Int. 2013 Feb; 12(1):34-41.
Score: 0.063
-
Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
Score: 0.062
-
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery. 2012 Sep; 152(3):376-81.
Score: 0.061
-
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep; 16(3):671-81.
Score: 0.061
-
Predicting the discharge status after liver transplantation at a single center: a new approach for a new era. Liver Transpl. 2012 Jul; 18(7):796-802.
Score: 0.061
-
Infectious complications after human small bowel transplantation. Transplant Proc. 1992 Jun; 24(3):1249-50.
Score: 0.060
-
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
Score: 0.060
-
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May; 14(5):325-32.
Score: 0.059
-
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis. 1992 Feb; 12(1):51-9.
Score: 0.059
-
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc. 1991 Dec; 23(6):3026-8.
Score: 0.058
-
Hepatic blood flow plays an important role in ischemia-reperfusion injury. Liver Transpl. 2011 Dec; 17(12):1448-56.
Score: 0.058
-
The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft. J Surg Res. 2012 May 01; 174(1):e37-45.
Score: 0.058
-
What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? Liver Transpl. 2011 Oct; 17 Suppl 2:S26-33.
Score: 0.057
-
Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
Score: 0.056
-
Splenic artery embolization for the treatment of refractory ascites after liver transplantation. Liver Transpl. 2011 Jun; 17(6):668-73.
Score: 0.056
-
Spur cell anemia as a cause of unconjugated hyperbilirubinemia after liver transplantation and its resolution after retransplantation. Liver Transpl. 2011 Mar; 17(3):349-50.
Score: 0.055
-
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc. 1991 Feb; 23(1 Pt 1):14-21.
Score: 0.055
-
Elevated catecholamines and hepatic artery vasospasm in porcine small-for-size liver graft. J Surg Res. 2012 May 01; 174(1):157-65.
Score: 0.054
-
Deep hypothermia with circulatory arrest to aid in the management of suprahepatic vena cava stenosis after liver transplantation. Liver Transpl. 2010 Dec; 16(12):1434-6.
Score: 0.054
-
Glucose balance of porcine liver allograft is an important predictor of outcome. J Surg Res. 2011 Dec; 171(2):851-8.
Score: 0.053
-
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990 Feb; 22(1):6-12.
Score: 0.051
-
Overview of FK506 in transplantation. Clin Transpl. 1990; 115-21.
Score: 0.051
-
Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 1990; 14 Suppl 1:49-63.
Score: 0.051
-
Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
Score: 0.051
-
Reversal of protein-losing enteropathy after liver transplantation in a child with idiopathic familial neonatal hepatitis. Liver Transpl. 2009 Dec; 15(12):1894-6.
Score: 0.051
-
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
Score: 0.050
-
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64.
Score: 0.050
-
Cruveilhier-Baumgarten disease in a patient with Turner syndrome: case report of a rare indication for liver transplantation. Liver Transpl. 2008 Mar; 14(3):299-302.
Score: 0.045
-
Triple-phase computed tomography and intraoperative flow measurements improve the management of portosystemic shunts during liver transplantation. Liver Transpl. 2008 Jan; 14(1):96-9.
Score: 0.044
-
Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl. 2008 Jan; 14(1):59-65.
Score: 0.044
-
World's longest surviving liver-pancreas recipient. Liver Transpl. 2007 Jul; 13(7):957-60.
Score: 0.043
-
Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
Score: 0.042
-
Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation. 2007 Mar 15; 83(5):656-62.
Score: 0.042
-
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant. 2006 Dec; 6(12):2983-93.
Score: 0.041
-
Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006 Aug; 30(8):986-93.
Score: 0.040
-
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006 Aug; 44(2):489-501.
Score: 0.040
-
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl. 2006 May; 12(5):813-20.
Score: 0.039
-
Isolated right hepatic vein obstruction after piggyback liver transplantation. Liver Transpl. 2006 May; 12(5):808-12.
Score: 0.039
-
Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report. Liver Transpl. 2006 Apr; 12(4):687-9.
Score: 0.039
-
Caroli's disease and orthotopic liver transplantation. Liver Transpl. 2006 Mar; 12(3):416-21.
Score: 0.039
-
Liver transplantation in HIV-seropositive individuals. Ann Intern Med. 2006 Feb 07; 144(3):223; author reply 223-4.
Score: 0.039
-
Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int. 2006 Jan; 19(1):27-37.
Score: 0.039
-
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 2005 Nov; 11(11):1343-52.
Score: 0.038
-
Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. J Clin Pharmacol. 2005 Jun; 45(6):666-73.
Score: 0.037
-
Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients. J Clin Pharmacol. 2005 Jan; 45(1):34-41.
Score: 0.036
-
Preliminary report on surgical technique in hepatic parenchymal transection for liver tumors in the elderly: a lesson learned from living-related liver transplantation. J Surg Oncol. 2004 Dec 15; 88(4):229-33.
Score: 0.036
-
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004 Oct 15; 78(7):966-71.
Score: 0.035
-
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
Score: 0.035
-
Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc. 2004 Sep; 36(7):1955-8.
Score: 0.035
-
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
Score: 0.034
-
Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl. 2004 Feb; 10(2):253-63.
Score: 0.034
-
Outcomes in 139 cases of biliary tract reconstructions from a transplant surgery center. Exp Clin Transplant. 2003 Dec; 1(2):73-8.
Score: 0.033
-
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation. 2003 Nov 27; 76(10):1487-91.
Score: 0.033
-
Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am J Transplant. 2003 Sep; 3(9):1173-81.
Score: 0.033
-
Tolerogenic immunosuppression for organ transplantation. Lancet. 2003 May 03; 361(9368):1502-10.
Score: 0.032
-
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantation. 2003 Apr 15; 75(7):1020-5.
Score: 0.032
-
Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report. Ther Drug Monit. 2003 Feb; 25(1):117-9.
Score: 0.032
-
Pancreatitis after liver transplantation in children: a single-center experience. Transplantation. 2003 Jan 27; 75(2):190-3.
Score: 0.031
-
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
Score: 0.030
-
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc. 2002 Aug; 34(5):1968-9.
Score: 0.030
-
Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury. Transplantation. 2002 Jul 15; 74(1):7-13.
Score: 0.030
-
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
Score: 0.030
-
Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci. 2002 Apr; 47(4):750-4.
Score: 0.030
-
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
Score: 0.030
-
Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology. 2002 Feb; 35(2):380-4.
Score: 0.029
-
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
Score: 0.029
-
Intestinal transplantation: a coming of age. Adv Surg. 2002; 36:65-101.
Score: 0.029
-
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation. 2001 Oct 27; 72(8 Suppl):S13-22.
Score: 0.029
-
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant. 2001 Oct; 5(5):359-64.
Score: 0.029
-
Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
Score: 0.029
-
Ethical considerations and rationale of adult-to-adult living donor liver transplantation. Liver Transpl. 2001 Oct; 7(10):921-7.
Score: 0.029
-
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
Score: 0.029
-
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
Score: 0.028
-
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol. 2001 Apr; 158(4):1379-90.
Score: 0.028
-
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):129-30.
Score: 0.027
-
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
Score: 0.027
-
Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts. Transplant Proc. 2001 Feb-Mar; 33(1-2):778.
Score: 0.027
-
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
Score: 0.027
-
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. Transplant Proc. 2000 Dec; 32(8):2710-2.
Score: 0.027
-
Use of non-heart-beating donors. Transplant Proc. 2000 Nov; 32(7):1510-1.
Score: 0.027
-
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000 Oct; 191(4):389-94.
Score: 0.027
-
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation. 2000 Aug 15; 70(3):543-5.
Score: 0.027
-
Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. Transplant Proc. 2000 Aug; 32(5):1109.
Score: 0.027
-
Loss of serum bicarbonate after discordant liver xenotransplantation. Transplant Proc. 2000 Aug; 32(5):1110.
Score: 0.027
-
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000 Jun 27; 69(12):2566-73.
Score: 0.026
-
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation. 2000 Jun 15; 69(11):2330-6.
Score: 0.026
-
Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar; 31(3):577-80.
Score: 0.026
-
Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc. 2000 Mar; 32(2):322-6.
Score: 0.026
-
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000 Mar; 6(2):163-9.
Score: 0.026
-
Serum protein immunogenicity: implications for liver xenografting. Electrophoresis. 2000 Mar; 21(5):965-75.
Score: 0.026
-
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation. 2000 Feb 15; 69(3):383-8.
Score: 0.026
-
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D. Liver Transpl. 2000 Jan; 6(1):92-6.
Score: 0.025
-
[Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center]. Nihon Geka Gakkai Zasshi. 1999 Dec; 100(12):818-21.
Score: 0.025
-
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999 Sep 15; 68(5):650-5.
Score: 0.025
-
Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. Liver Transpl Surg. 1999 Sep; 5(5):429-36.
Score: 0.025
-
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
Score: 0.025
-
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999 Jul; 117(1):149-53.
Score: 0.025
-
Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat. Xenotransplantation. 1999 May; 6(2):117-22.
Score: 0.024
-
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Liver Transpl Surg. 1999 Mar; 5(2):101-6.
Score: 0.024
-
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Transplantation. 1999 Feb 15; 67(3):444-50.
Score: 0.024
-
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors. Transplant Proc. 1999 Feb-Mar; 31(1-2):453.
Score: 0.024
-
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Transplant Proc. 1999 Feb-Mar; 31(1-2):488-9.
Score: 0.024
-
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1244.
Score: 0.024
-
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998 Dec 27; 66(12):1596-604.
Score: 0.024
-
Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation. 1998 Dec 15; 66(11):1545-51.
Score: 0.024
-
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1998 Oct 27; 66(8):1047-52.
Score: 0.023
-
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998 Oct 15; 66(7):956-62.
Score: 0.023
-
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998 Oct; 187(4):358-64.
Score: 0.023
-
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
Score: 0.023
-
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis. 1998 Jun; 31(6 Suppl 1):S7-14.
Score: 0.023
-
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Transplant Proc. 1998 Jun; 30(4):1091-2.
Score: 0.023
-
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation. 1998 Mar 15; 65(5):619-24.
Score: 0.022
-
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.
Score: 0.022
-
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
Score: 0.022
-
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998 Jan 15; 65(1):82-6.
Score: 0.022
-
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
Score: 0.022
-
Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997 Nov; 185(5):429-36.
Score: 0.022
-
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct; 26(4):877-83.
Score: 0.022
-
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation. 1997 Sep 15; 64(5):786-8.
Score: 0.022
-
Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997 Aug 27; 64(4):559-65.
Score: 0.022
-
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation. 1997 Aug 15; 64(3):422-6.
Score: 0.022
-
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997 Aug; 26(2):444-50.
Score: 0.022
-
Early recipient-donor switch of the complement type after liver xenotransplantation. Immunol Invest. 1997 Aug-Dec; 26(5-7):589-600.
Score: 0.022
-
Central venulitis in the allograft liver: a clinicopathologic study. Transplantation. 1997 Jul 27; 64(2):252-7.
Score: 0.022
-
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma? JAMA. 1997 Jul 16; 278(3):203-5.
Score: 0.021
-
Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
Score: 0.021
-
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997 May 15; 158(10):4654-61.
Score: 0.021
-
Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May; 3(3):240-4.
Score: 0.021
-
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc. 1997 Feb-Mar; 29(1-2):454-5.
Score: 0.021
-
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc. 1997 Feb-Mar; 29(1-2):532-3.
Score: 0.021
-
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1174-7.
Score: 0.021
-
Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997 Jan 27; 63(2):243-9.
Score: 0.021
-
Gastrointestinal bleeding after liver transplantation. Transplantation. 1997 Jan 15; 63(1):60-7.
Score: 0.021
-
Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int. 1997; 10(2):133-6.
Score: 0.021
-
Liver transplantation for acute liver failure: outcome analysis. J Viral Hepat. 1997; 4 Suppl 1:107-10.
Score: 0.021
-
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant. 1997; 2(2):27-44.
Score: 0.021
-
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996 Oct; 28(5):2959-65.
Score: 0.020
-
The patient with chronic hepatitis C. Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):73-8.
Score: 0.020
-
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation. 1996 Jun 27; 61(12):1730-5.
Score: 0.020
-
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc. 1996 Jun; 28(3):1229-34.
Score: 0.020
-
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc. 1996 Jun; 28(3):1237-40.
Score: 0.020
-
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis. 1996 May; 173(5):1072-6.
Score: 0.020
-
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. Transplantation. 1996 Apr 27; 61(8):1228-33.
Score: 0.020
-
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. Transplant Proc. 1996 Apr; 28(2):735.
Score: 0.020
-
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg. 1996 Mar; 2(2):139-47.
Score: 0.020
-
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res. 1996 Feb 01; 60(2):333-8.
Score: 0.019
-
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg. 1996 Jan; 223(1):70-6.
Score: 0.019
-
Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
Score: 0.019
-
Human islet transplantation: results of the first 37 patients. Transplant Proc. 1995 Dec; 27(6):3162-3.
Score: 0.019
-
Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet. 1995 Nov 18; 346(8986):1346-50.
Score: 0.019
-
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol. 1995 Nov; 2(6):483-7.
Score: 0.019
-
Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc. 1995 Oct; 27(5):2898.
Score: 0.019
-
Patterns of inflammatory vascular endothelial changes in murine liver grafts. Transplantation. 1995 Sep 27; 60(6):577-84.
Score: 0.019
-
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. Transplantation. 1995 Sep 27; 60(6):619-21.
Score: 0.019
-
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation. 1995 Sep 15; 60(5):512-4.
Score: 0.019
-
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
Score: 0.019
-
Rejection triggers liver transplant tolerance: Involvement of mesenchyme-mediated immune control mechanisms in mice. Hepatology. 2015 Sep; 62(3):915-31.
Score: 0.019
-
Building clinical classifiers using incomplete observations--a neural network ensemble for hepatoma detection in patients with cirrhosis. Methods Inf Med. 1995 Jun; 34(3):253-8.
Score: 0.019
-
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization. Immunology. 1995 May; 85(1):82-7.
Score: 0.018
-
Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology. 1995 May; 21(5):1345-52.
Score: 0.018
-
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc. 1995 Apr; 27(2):1862-7.
Score: 0.018
-
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
Score: 0.018
-
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
Score: 0.018
-
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. Transplant Proc. 1995 Feb; 27(1):277.
Score: 0.018
-
Mechanisms of protection from humoral rejection by a xenografted liver. Transplant Proc. 1995 Feb; 27(1):300-2.
Score: 0.018
-
Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
Score: 0.018
-
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol. 1995 Feb; 19(2):192-206.
Score: 0.018
-
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc. 1995 Feb; 27(1):1193-4.
Score: 0.018
-
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transplant Proc. 1995 Feb; 27(1):191-3.
Score: 0.018
-
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
Score: 0.018
-
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc. 1995 Feb; 27(1):67-70.
Score: 0.018
-
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
Score: 0.018
-
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation. 1995 Jan 27; 59(2):212-7.
Score: 0.018
-
Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int. 1995; 8(1):1-7.
Score: 0.018
-
FK 506 in solid organ transplantation. Transplant Proc. 1994 Oct; 26(5):3017-20.
Score: 0.018
-
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994 Sep; 220(3):297-308; discussion 308-9.
Score: 0.018
-
Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
Score: 0.017
-
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant. 1994 Jul-Aug; 3(4):345-8.
Score: 0.017
-
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994 Jul; 20(1 Pt 2):56S-62S.
Score: 0.017
-
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. Transplant Proc. 1994 Jun; 26(3):1208.
Score: 0.017
-
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. Transplant Proc. 1994 Jun; 26(3):1255.
Score: 0.017
-
Prospects of clinical xenotransplantation. Transplant Proc. 1994 Jun; 26(3):1082-8.
Score: 0.017
-
Metabolic changes in the recipient after successful liver xenotransplantation in the rat. Transplant Proc. 1994 Jun; 26(3):1207.
Score: 0.017
-
Ex vivo normothermic machine perfusion is safe, simple, and reliable: results from a large animal model. Surg Innov. 2015 Feb; 22(1):61-9.
Score: 0.017
-
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr; 19(4):916-24.
Score: 0.017
-
Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation. 1994 Mar 27; 57(6):918-22.
Score: 0.017
-
Prioritization and organ distribution for liver transplantation. JAMA. 1994 Jan 12; 271(2):140-3.
Score: 0.017
-
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation. 1994 Jan; 57(1):149-51.
Score: 0.017
-
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg. 1994 Jan; 219(1):40-5.
Score: 0.017
-
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc. 1993 Dec; 25(6):3337-44.
Score: 0.017
-
Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993 Nov 01; 72(9):2568-73.
Score: 0.017
-
Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation. ASAIO J. 1993 Oct-Dec; 39(4):954-6.
Score: 0.017
-
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct; 177(4):335-44.
Score: 0.017
-
Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
Score: 0.016
-
Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation. 1993 Aug; 56(2):489-90.
Score: 0.016
-
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol. 1993 Jul; 143(1):85-98.
Score: 0.016
-
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc. 1993 Jun; 25(3):2381-5.
Score: 0.016
-
Clinical intestinal transplantation. Transplant Proc. 1993 Jun; 25(3):2195-7.
Score: 0.016
-
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol. 1993 May; 142(5):1383-91.
Score: 0.016
-
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation. 1993 Mar; 55(3):659-61.
Score: 0.016
-
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc. 1993 Feb; 25(1 Pt 1):414-5.
Score: 0.016
-
Two-year experience with FK 506 in pediatric patients. Transplant Proc. 1993 Feb; 25(1 Pt 1):619-21.
Score: 0.016
-
Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 1):647-8.
Score: 0.016
-
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc. 1993 Feb; 25(1 Pt 2):888-90.
Score: 0.016
-
Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc. 1992 Dec; 24(6):3038-9.
Score: 0.016
-
Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992 Sep; 216(3):223-33; discussion 233-4.
Score: 0.015
-
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc. 1992 Aug; 24(4):1403-5.
Score: 0.015
-
Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc. 1992 Aug; 24(4):1605-6.
Score: 0.015
-
Clinical intestinal transplantation: focus on complications. Transplant Proc. 1992 Jun; 24(3):1238-40.
Score: 0.015
-
Human islet allotransplantation in 18 diabetic patients. Transplant Proc. 1992 Jun; 24(3):961.
Score: 0.015
-
Survival of human hepatocellular aggregates in athymic mice. Transplant Proc. 1992 Jun; 24(3):986.
Score: 0.015
-
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
Score: 0.015
-
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol. 1992 May; 140(5):1255-60.
Score: 0.015
-
Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation. 1992 Feb; 53(2):369-76.
Score: 0.015
-
Detection of intrahepatic human islets following combined liver-islet allotransplantation. Pancreas. 1992; 7(4):507-9.
Score: 0.015
-
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc. 1991 Dec; 23(6):2771-4.
Score: 0.015
-
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc. 1991 Dec; 23(6):2873-4.
Score: 0.015
-
FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc. 1991 Dec; 23(6):3010-5.
Score: 0.015
-
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. Transplant Proc. 1991 Dec; 23(6):3016-8.
Score: 0.015
-
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc. 1991 Dec; 23(6):3021-2.
Score: 0.015
-
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc. 1991 Dec; 23(6):3023-5.
Score: 0.015
-
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3035-7.
Score: 0.015
-
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc. 1991 Dec; 23(6):3044-6.
Score: 0.015
-
Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3093-5.
Score: 0.015
-
Changes in renal function after liver transplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3143-5.
Score: 0.015
-
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. Transplant Proc. 1991 Dec; 23(6):3148-9.
Score: 0.015
-
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc. 1991 Dec; 23(6):3322-4.
Score: 0.015
-
FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):3005-6.
Score: 0.015
-
Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep; 52(3):562-4.
Score: 0.014
-
Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc. 1991 Jun; 23(3):1917-21.
Score: 0.014
-
The many faces of multivisceral transplantation. Surg Gynecol Obstet. 1991 May; 172(5):335-44.
Score: 0.014
-
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 1991 Apr; 13(4):619-26.
Score: 0.014
-
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol. 1991 Mar; 138(3):609-18.
Score: 0.014
-
Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. Transplantation. 1991 Mar; 51(3):727-8.
Score: 0.014
-
The spectrum of portal vein thrombosis in liver transplantation. Ann Surg. 1991 Mar; 213(3):199-206.
Score: 0.014
-
Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
Score: 0.014
-
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc. 1991 Feb; 23(1 Pt 2):1397-402.
Score: 0.014
-
Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc. 1991 Feb; 23(1 Pt 1):705-6.
Score: 0.014
-
The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
Score: 0.014
-
Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
Score: 0.014
-
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol. 1990 Sep; 137(3):667-76.
Score: 0.013
-
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990 Aug 18; 336(8712):402-5.
Score: 0.013
-
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation. 1990 Aug; 50(2):186-9.
Score: 0.013
-
Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc. 1990 Feb; 22(1):25-34.
Score: 0.013
-
Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc. 1990 Feb; 22(1):41-3.
Score: 0.013
-
Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc. 1990 Feb; 22(1):44-6.
Score: 0.013
-
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc. 1990 Feb; 22(1):57-9.
Score: 0.013
-
Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner. Transplantation. 2008 Dec 15; 86(11):1492-502.
Score: 0.012
-
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation. 1988 Sep; 46(3):372-7.
Score: 0.012
-
Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug; 208(2):196-202.
Score: 0.012
-
Immunological factors influencing liver graft survival. Gastroenterol Clin North Am. 1988 Mar; 17(1):53-9.
Score: 0.011
-
Effect of OKT3 on survival and rate of retransplantation. Transplant Proc. 1987 Aug; 19(4 Suppl 3):61-2.
Score: 0.011
-
HLA histocompatibility and liver transplant survival. Transplant Proc. 1987 Aug; 19(4 Suppl 3):63-5.
Score: 0.011
-
OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 3):2443-6.
Score: 0.010
-
Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc. 1987 Feb; 19(1 Pt 3):2470-3.
Score: 0.010
-
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron. 1987; 46 Suppl 1:19-33.
Score: 0.010
-
The antibody crossmatch in liver transplantation. Surgery. 1986 Oct; 100(4):705-15.
Score: 0.010
-
Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin Infect Dis. 2003 Jul 01; 37(1):17-25.
Score: 0.008
-
Rapid temporary portosystemic bypass. Dig Dis Sci. 2002 Feb; 47(2):448-9.
Score: 0.007
-
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
Score: 0.007
-
Bacterial translocation in clinical intestinal transplantation. Transplant Proc. 2000 Sep; 32(6):1210.
Score: 0.007
-
Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc. 2000 Sep; 32(6):1213.
Score: 0.007
-
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc. 2000 Sep; 32(6):1223-4.
Score: 0.007
-
Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol. 1999 Aug; 66(2):310-4.
Score: 0.006
-
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.
Score: 0.006
-
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998 Nov; 43(11):2459-62.
Score: 0.006
-
Long-term nutritional monitoring after clinical intestinal transplantation. Transplant Proc. 1998 Sep; 30(6):2515-6.
Score: 0.006
-
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
Score: 0.006
-
Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance. Hum Pathol. 1998 Apr; 29(4):416-21.
Score: 0.006
-
Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb; 33(2):243-54.
Score: 0.006
-
Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
Score: 0.005
-
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation. 1997 Sep 15; 64(5):690-5.
Score: 0.005
-
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc. 1997 May; 29(3):1905-6.
Score: 0.005
-
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol. 1997 Feb; 150(2):563-78.
Score: 0.005
-
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997 Feb-Mar; 29(1-2):1184-5.
Score: 0.005
-
Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc. 1997 Feb-Mar; 29(1-2):746-7.
Score: 0.005
-
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan; 180(1):1-9.
Score: 0.005
-
Three years clinical experience with intestinal transplantation. J Am Coll Surg. 1994 Oct; 179(4):385-400.
Score: 0.004
-
Intestinal transplantation in humans under FK 506. Transplant Proc. 1993 Feb; 25(1 Pt 2):1198-9.
Score: 0.004
-
Nutritional management of intestinal transplant recipients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1200-1.
Score: 0.004
-
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol. 1992 Jun; 128(6):781-5.
Score: 0.004
-
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc. 1992 Jun; 24(3):1143-4.
Score: 0.004
-
Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc. 1992 Jun; 24(3):1199-200.
Score: 0.004
-
Human islet allotransplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3207.
Score: 0.004
-
[Clinical experience with FK 506]. Presse Med. 1991 Nov 27; 20(40):1967-73.
Score: 0.004
-
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
Score: 0.004
-
Use of FK 506 in pediatric patients. Transplant Proc. 1991 Feb; 23(1 Pt 2):924-7.
Score: 0.003
-
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
Score: 0.003
-
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990 Sep; 212(3):295-305; discussion 306-7.
Score: 0.003
-
The side effects of FK 506 in humans. Transplant Proc. 1990 Feb; 22(1):35-6.
Score: 0.003